Decision Diagnostics Corp. (DECN)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2022 | - USD | 0.0% |
| 2021 | - USD | -100.0% |
| 2020 | 2.29 Million USD | -14.38% |
| 2019 | 2.68 Million USD | 128.71% |
| 2018 | 1.17 Million USD | 24.63% |
| 2017 | 940.32 Thousand USD | -1.0% |
| 2016 | 949.8 Thousand USD | 118.98% |
| 2015 | 433.74 Thousand USD | 0.0% |
| 2012 | 2.38 Million USD | 10.22% |
| 2011 | 2.15 Million USD | 9.71% |
| 2010 | 1.96 Million USD | -2.58% |
| 2009 | 2.02 Million USD | -35.06% |
| 2008 | 3.11 Million USD | 47.71% |
| 2007 | 2.1 Million USD | 20.67% |
| 2006 | 1.74 Million USD | 151.47% |
| 2005 | 694.28 Thousand USD | 77.92% |
| 2004 | 390.23 Thousand USD | -39.25% |
| 2003 | 642.4 Thousand USD | 66.86% |
| 2002 | 385 Thousand USD | -67.21% |
| 2001 | 1.17 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q2 | - USD | 0.0% |
| 2023 Q3 | - USD | 0.0% |
| 2023 Q1 | - USD | 0.0% |
| 2022 FY | - USD | 0.0% |
| 2022 Q3 | - USD | 0.0% |
| 2022 Q4 | - USD | 0.0% |
| 2021 FY | - USD | -100.0% |
| 2021 Q1 | 2.48 Million USD | 8.13% |
| 2021 Q2 | 2.92 Million USD | 17.92% |
| 2021 Q3 | 3.02 Million USD | 3.43% |
| 2020 Q4 | 2.29 Million USD | -16.6% |
| 2020 FY | 2.29 Million USD | -14.38% |
| 2020 Q2 | 2.24 Million USD | -13.53% |
| 2020 Q3 | 2.75 Million USD | 22.67% |
| 2020 Q1 | 2.59 Million USD | -3.21% |
| 2019 FY | 2.68 Million USD | 128.71% |
| 2019 Q2 | 1 Million USD | -28.21% |
| 2019 Q3 | 1.06 Million USD | 5.77% |
| 2019 Q4 | 2.68 Million USD | 151.21% |
| 2019 Q1 | 1.4 Million USD | 19.91% |
| 2018 Q4 | 1.17 Million USD | 8.16% |
| 2018 FY | 1.17 Million USD | 24.63% |
| 2018 Q1 | 764.11 Thousand USD | -18.74% |
| 2018 Q2 | 604.28 Thousand USD | -20.92% |
| 2018 Q3 | 1.08 Million USD | 79.31% |
| 2017 Q3 | 1.46 Million USD | 0.0% |
| 2017 Q1 | 1.06 Million USD | 12.15% |
| 2017 FY | 940.32 Thousand USD | -1.0% |
| 2017 Q4 | 940.32 Thousand USD | -35.7% |
| 2016 Q1 | -76.4 Thousand USD | -117.64% |
| 2016 FY | 949.8 Thousand USD | 118.98% |
| 2016 Q4 | 949.8 Thousand USD | 29.93% |
| 2016 Q3 | 731.03 Thousand USD | 117.65% |
| 2016 Q2 | 335.87 Thousand USD | 539.62% |
| 2015 Q3 | 698.4 Thousand USD | -55.35% |
| 2015 Q4 | 433.04 Thousand USD | -37.99% |
| 2015 Q1 | 1.31 Million USD | 0.0% |
| 2015 Q2 | 1.56 Million USD | 19.31% |
| 2015 FY | 433.74 Thousand USD | 0.0% |
| 2013 Q1 | 2.45 Million USD | 3.3% |
| 2013 Q3 | 3.05 Million USD | 10.35% |
| 2013 Q2 | 2.76 Million USD | 12.51% |
| 2012 Q1 | 2.17 Million USD | 0.66% |
| 2012 Q2 | 2.27 Million USD | 4.58% |
| 2012 Q3 | 2.44 Million USD | 7.46% |
| 2012 Q4 | 2.38 Million USD | -2.57% |
| 2012 FY | 2.38 Million USD | 10.22% |
| 2011 Q4 | 2.15 Million USD | 3.4% |
| 2011 Q2 | 1.62 Million USD | 500.49% |
| 2011 FY | 2.15 Million USD | 9.71% |
| 2011 Q1 | -404.59 Thousand USD | -120.55% |
| 2011 Q3 | 2.08 Million USD | 28.92% |
| 2010 FY | 1.96 Million USD | -2.58% |
| 2010 Q1 | 1 Million USD | -50.05% |
| 2010 Q2 | 1.03 Million USD | 2.8% |
| 2010 Q3 | 915.64 Thousand USD | -11.77% |
| 2010 Q4 | 1.96 Million USD | 115.02% |
| 2009 Q4 | 2.02 Million USD | 27.21% |
| 2009 Q1 | 2.64 Million USD | -15.07% |
| 2009 FY | 2.02 Million USD | -35.06% |
| 2009 Q2 | 2.14 Million USD | -19.0% |
| 2009 Q3 | 1.58 Million USD | -25.79% |
| 2008 FY | 3.11 Million USD | 47.71% |
| 2008 Q1 | 2.02 Million USD | -3.71% |
| 2008 Q2 | 2.16 Million USD | 6.87% |
| 2008 Q3 | 2.44 Million USD | 12.85% |
| 2008 Q4 | 3.11 Million USD | 27.2% |
| 2007 FY | 2.1 Million USD | 20.67% |
| 2007 Q2 | 1.79 Million USD | 12.66% |
| 2007 Q1 | 1.59 Million USD | -8.51% |
| 2007 Q3 | 1.54 Million USD | -13.88% |
| 2007 Q4 | 2.1 Million USD | 35.95% |
| 2006 FY | 1.74 Million USD | 151.47% |
| 2006 Q4 | 1.74 Million USD | 4.73% |
| 2006 Q3 | 1.66 Million USD | 21.91% |
| 2006 Q1 | 721.09 Thousand USD | 3.86% |
| 2006 Q2 | 1.36 Million USD | 89.63% |
| 2005 Q1 | -533.16 Thousand USD | -236.63% |
| 2005 Q4 | 694.28 Thousand USD | 10414.78% |
| 2005 Q3 | -6731.00 USD | 98.16% |
| 2005 Q2 | -366.63 Thousand USD | 31.23% |
| 2005 FY | 694.28 Thousand USD | 77.92% |
| 2004 FY | 390.23 Thousand USD | -39.25% |
| 2004 Q4 | 390.23 Thousand USD | 155.17% |
| 2004 Q3 | 152.93 Thousand USD | 121.06% |
| 2004 Q2 | 69.18 Thousand USD | -51.71% |
| 2004 Q1 | 143.26 Thousand USD | -77.7% |
| 2003 Q2 | 648.8 Thousand USD | 26.47% |
| 2003 FY | 642.4 Thousand USD | 66.86% |
| 2003 Q4 | 642.4 Thousand USD | 14.66% |
| 2003 Q1 | 512.99 Thousand USD | 33.24% |
| 2003 Q3 | 560.25 Thousand USD | -13.65% |
| 2002 Q2 | 273.97 Thousand USD | -87.82% |
| 2002 Q1 | 2.24 Million USD | 0.0% |
| 2002 FY | 385 Thousand USD | -67.21% |
| 2002 Q3 | 135.61 Thousand USD | -50.5% |
| 2002 Q4 | 385 Thousand USD | 183.9% |
| 2001 FY | 1.17 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Alternative Energy Partners, Inc. | 415.78 Thousand USD | 100.0% |
| Allstar Health Brands, Inc. | 2.21 Million USD | 100.0% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | -111.13 Million USD | 100.0% |
| Café Serendipity Holdings, Inc. | 409.94 Thousand USD | 100.0% |
| Health Advance Inc. | 271.74 Thousand USD | 100.0% |
| HealthWarehouse.com, Inc. | 2.17 Million USD | 100.0% |
| LIGAND PHARMACEUTICAL INC | -16.78 Million USD | 100.0% |
| MedGen, Inc. | 24.36 USD | 100.0% |
| Omni Health, Inc. | 1.46 Million USD | 100.0% |
| Oxford Investments Holdings Inc. | 172.66 Thousand USD | 100.0% |
| Pineapple, Inc. | 8.1 Million USD | 100.0% |
| ScripsAmerica, Inc. | 748.59 Thousand USD | 100.0% |